UJI KLINIK EFEK FORMULA JAMU PENURUN KOLESTEROL DARAH TERHADAP FUNGSI HATI
Keywords:
uji klinik, formula jamu hiperkolesterolemia, fungsi hatiAbstract
Hiperkolesterolemia merupakan penyakit degeneratif yang sering memerlukan pengobatan seumur hidup. Hiperkolesterolemia sebagai faktor resiko aterosklerosis yang bisa menyebabkan kematian. Telah dilakukan penelitian efek formula jamu penurun kolesterol darah terhadap fungsi hati (SGOT dan SGPT). Uji klinik dilakukan dengan desain penelitian pre-post test design pada 85 subjek penelitian laki laki dan perempuan usia 25 - 55 tahun. Subjek penelitian minum formula jamu selama enam minggu dengan kontrol seminggu sekali. Dilakukan observasi kinik serta pemeriksaan SGOT dan SGPT pada awal penelitian, hari ke-21 dan hari ke-42. Hasil pemeriksaan SGOT dan SGPT dianalisis dengan uji t berpasangan. Hasil uji t berpasangan sebelum perlakuan dibanding sesudah perlakuan 21 hari untuk kadar SGOT nilai p 0.313 dan kadar SGPT nilai p 0.286. Hasil uji t berpasangan sebelum perlakuan dibanding sesudah perlakuan 42 hari untuk kadar SGOT nilai p 0.204 dan kadar SGPT nilai p 0.280. Tidak ada perbedaan bermakna (p>0.05) kadar SGOT dan SGPT sebelum perlakuan dibanding setelah perlakuan 21 hari dan 42 hari. Jadi disimpulkan bahwa penggunaan formula jamu penurun kolesterol darah selama 42 hari tidak mengganggu fungsi hati.
Downloads
References
Cahyono JBSB. (2009) : Hepatitis A. Yogyakarta : Kanisius yogyakarta
Chandrasoma, P. dan Taylor, C. R. (2005) : Ringkasaan Patologi Anatomi. Jakarta EGC
Ganong, W. F. (2008) : Buku Ajar Fisiologi Kedokteran Edisi 22. Jakarta: EGC.
Horrison. (2001) : Principles of Internal Medicine, 15 th edition, Mc Grow Hill, New York.
Isabel, M., et al. (2008) : Assessment of drug-induced liver injury in clinical practice Assessment of drug-induced liver injury in clinical practice, Agencia Espan˜-ola del Medicamento and from the Fondo de Investigacio´ n Sanitaria.
Kee, Joyce Le Fever. (2007) : Pedoman Pemeriksaan Laboraturium & Diagnostik. Edisi 6. Jakarta : EGC.
Kosasih, E.N dan A.S Kosasih. (2008) : Tafsiran Hasil pemeriksaan Laboratorium Klinik edisi kedua. Karisma Publishing Group : Tangerang.
Lee D.(2012) : Drug Induced Liver Disease. URL : www.medicineNet.com. September 26.
Lucena, M.I., Cortes, M.G., Cueto, R., Duran, J.L.L., dan Andrade, R.J.,2008. Assessment of Drug Induced Injuy in Clinical Practice, Fundamental & Clinical Pharmacology.
Mayes PA.(2001) : Sintesis, Pengangkutan, dan Ekskresi Kolesterol. Dalam : Biokimia Harper. Edisi ke-25. Alih Bahasa : Hartono A. Jakarta: EGC; p. 270-281.
Menkes RI. ( 2012) :Permenkes Nomor 007 Tahun 2012 Tentang Registrasi Obat Tradisional
Menkes. (2003) : Keputusan Menteri Kesehatan RI Nomor 1076/Menkes/SK/VII/2003 tentang Penyelenggaraan Pengobatan Tradisional. Jakarta.
Mc.Gilvery, R.W.and Golstein, G.W.(1996) : Biokimia Suatu Pendekatan Fungsional, Edisi ketiga, Airlangga University Press, Jakarta
Pratt, D.S. (2010) : Liver Chemistry and function test. In:Feldma M, Friedma, L.S., Brandt, L.J., eds. Scheisenger and Fordtran’s Gastrointestinal and Liver disease. Saunders Elsevier, Philadelphia, PA.
Robbins, et al. (2007) : Buku Ajar Patologi Vol. 2. Penerbit Buku Kedokteran EGC: Jakarta
Ronald et al. (2004) : Tinjauan Kilis Hasil Pemeriksaan Laboratorium. Jakarta: EGC
Setiabudy, R.(1979) : Hepatitis Karena Obat, Cermin Dunia Kedokteran,15: 8-12.
Setiawan, Poernomo Budi. (2007) : Sirosis Hati. In: Buku Ajar Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Airlangga, Rumah Sakit Pendidikan Dr. Soetomo Surabaya. Surabaya: Airlangga University Press
Sonderup, M.W. (2006) : Drug Induced Liver Injury is a Significant Cause of Liver Disease, Including Chronic Liver, Drug Induced Liver Injuries, 29 (6).
Triyono A. (2015) : Laporan Penelitian Uji Klinik Formula Jamu Hiperkolesterolemia Dibanding Simvastatin. B2P2TO2T.
Price, A. dan Wilson, L. (1995) : Patofisiologi. Buku 2. Edisi 4. Penebit Buku Kedokteran EGC. Jakarta, hal :1117-1119
WHO. (2011) : Cardio Vascular Disease. Available from : http://www.who.int/ mediacentre/factsheets/fs317/en/index.html Access on : 22 September 2015.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Authors who publish in Jurnal Farmasi Galenika agree to the following terms:
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. CC BY includes the following elements:
BY: credit must be given to the creator.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.